BioMendics
PrivateLast Round
Seed
Sep 4, 2016
Total Funding Raised
$25,000
Company Overview
BioMendics is a clinical-stage biotechnology company that develops innovative topical therapeutics for rare genetic and dermatologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMendics Comparables
Compare BioMendics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mariposa Therapeutics | 85% | |
| Aegle Therapeutics Corp | 80% | |
| Nova Anchora | 76% | |
BioMendics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 4, 2016 | ||||
| Grant | Dec 10, 2014 |
BioMendics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 1107% MoM, from 61 to 736.
BioMendics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioMendics's valuation, stock price, and market status.